Topline In a glimmer of hope for one of this year’s worst-performing stocks, Morgan Stanley analyst Matthew Harrison projected incoming results for one of Moderna’s flu vaccine candidates ...
Topline In a glimmer of hope for one of this year’s worst-performing stocks, Morgan Stanley analyst Matthew Harrison projected incoming results for one of Moderna’s flu vaccine candidates ...